This research letter aims at highlighting the contribution of cardiologists in the management of primary hyperoxaluria type I (PH1), a disease with recent therapeutic innovation that can potentially change its natural history.
Oxalic Cardiomyopathy: Could it Influence Treatment Plans in Patients With Primary Hyperoxaluria Type 1?
Di Toro, Alessandro;Urtis, Mario;Pellegrini, Carlo;Smirnova, Alexandra;Valentini, Adele;Arbustini, Eloisa
2021-01-01
Abstract
This research letter aims at highlighting the contribution of cardiologists in the management of primary hyperoxaluria type I (PH1), a disease with recent therapeutic innovation that can potentially change its natural history.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
